Hepatitis Health Center

November 14, 2014 3:48 PM

3 0

FRIDAY, Nov. 14, 2014 (HealthDay News) -- A new drug regimen is producing high cure rates in small groups of liver transplant patients with hepatitis C, researchers report.

The study's results are a "landmark achievement," said study first author Dr. Paul Kwo, professor of medicine at the Indiana University School of Medicine, in a university news release.

Also read: Drake takes out Indiana State 87-70 using balanced scoring

Read more

To category page